Shandong Xinhua Pharmaceutical Company Limited (0719.HK)
HKD 5.49
(0.0%)
HKD 5.49
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 440.35 Million CNY | 95.62% |
| 2022 | 225.11 Million CNY | -24.73% |
| 2021 | 299.09 Million CNY | 29.05% |
| 2020 | 231.76 Million CNY | -70.63% |
| 2019 | 789.16 Million CNY | 34.7% |
| 2018 | 585.85 Million CNY | 32.6% |
| 2017 | 441.83 Million CNY | -44.32% |
| 2016 | 793.52 Million CNY | -22.01% |
| 2015 | 1.01 Billion CNY | -11.22% |
| 2014 | 1.14 Billion CNY | 16.5% |
| 2013 | 983.71 Million CNY | 24.7% |
| 2012 | 788.87 Million CNY | 102.67% |
| 2011 | 389.23 Million CNY | 444.56% |
| 2010 | 71.47 Million CNY | 1008.19% |
| 2009 | -7.87 Million CNY | -116.98% |
| 2008 | 46.35 Million CNY | 952.2% |
| 2007 | -5.43 Million CNY | -107.48% |
| 2006 | 72.69 Million CNY | 30.33% |
| 2005 | 55.77 Million CNY | -74.45% |
| 2004 | 218.35 Million CNY | 648.21% |
| 2003 | -39.83 Million CNY | 75.63% |
| 2002 | -163.46 Million CNY | 42.63% |
| 2001 | -284.93 Million CNY | -1315.75% |
| 2000 | -20.12 Million CNY | -140.47% |
| 1999 | 49.72 Million CNY | -83.91% |
| 1998 | 309.07 Million CNY | 878.0% |
| 1997 | 31.6 Million CNY | -54.33% |
| 1996 | 69.19 Million CNY | -73.66% |
| 1995 | 262.71 Million CNY | 32.76% |
| 1994 | 197.89 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 393.53 Million CNY | -10.63% |
| 2024 Q3 | 202.21 Million CNY | -50.1% |
| 2024 Q2 | 405.99 Million CNY | 3.17% |
| 2023 FY | 440.35 Million CNY | 95.62% |
| 2023 Q1 | 473.7 Million CNY | 110.43% |
| 2023 Q2 | 355.71 Million CNY | -24.91% |
| 2023 Q4 | 440.35 Million CNY | -17.22% |
| 2023 Q3 | 531.99 Million CNY | 49.55% |
| 2022 FY | 225.11 Million CNY | -24.73% |
| 2022 Q1 | 730.37 Million CNY | 144.2% |
| 2022 Q4 | 225.11 Million CNY | -66.02% |
| 2022 Q2 | 571.64 Million CNY | -21.73% |
| 2022 Q3 | 662.49 Million CNY | 15.89% |
| 2021 FY | 299.09 Million CNY | 29.05% |
| 2021 Q1 | 205.66 Million CNY | -11.26% |
| 2021 Q2 | 179.16 Million CNY | -12.88% |
| 2021 Q3 | 284.7 Million CNY | 58.91% |
| 2021 Q4 | 299.09 Million CNY | 5.05% |
| 2020 Q4 | 231.76 Million CNY | 127.84% |
| 2020 Q3 | 101.72 Million CNY | -14.49% |
| 2020 Q2 | 118.95 Million CNY | -27.31% |
| 2020 Q1 | 163.65 Million CNY | -79.26% |
| 2020 FY | 231.76 Million CNY | -70.63% |
| 2019 FY | 789.16 Million CNY | 34.7% |
| 2019 Q1 | 691.7 Million CNY | 18.07% |
| 2019 Q2 | 704.91 Million CNY | 1.91% |
| 2019 Q3 | 811.52 Million CNY | 15.12% |
| 2019 Q4 | 789.16 Million CNY | -2.76% |
| 2018 Q2 | 383.33 Million CNY | -24.58% |
| 2018 Q3 | 468.3 Million CNY | 22.17% |
| 2018 FY | 585.85 Million CNY | 32.6% |
| 2018 Q4 | 585.85 Million CNY | 25.1% |
| 2018 Q1 | 508.26 Million CNY | 15.04% |
| 2017 FY | 441.83 Million CNY | -44.32% |
| 2017 Q4 | 441.83 Million CNY | -28.3% |
| 2017 Q3 | 616.26 Million CNY | -35.69% |
| 2017 Q2 | 958.25 Million CNY | 10.98% |
| 2017 Q1 | 863.47 Million CNY | 8.82% |
| 2016 FY | 793.52 Million CNY | -22.01% |
| 2016 Q4 | 793.52 Million CNY | -6.04% |
| 2016 Q1 | 1.04 Billion CNY | 2.62% |
| 2016 Q2 | 1.02 Billion CNY | -2.29% |
| 2016 Q3 | 844.5 Million CNY | -17.21% |
| 2015 Q1 | 1.19 Billion CNY | 4.14% |
| 2015 Q4 | 1.01 Billion CNY | -2.96% |
| 2015 FY | 1.01 Billion CNY | -11.22% |
| 2015 Q3 | 1.04 Billion CNY | -4.25% |
| 2015 Q2 | 1.09 Billion CNY | -8.26% |
| 2014 Q1 | 1.01 Billion CNY | 2.93% |
| 2014 Q3 | 1.09 Billion CNY | -0.67% |
| 2014 Q4 | 1.14 Billion CNY | 4.71% |
| 2014 FY | 1.14 Billion CNY | 16.5% |
| 2014 Q2 | 1.1 Billion CNY | 8.82% |
| 2013 Q4 | 983.71 Million CNY | -4.46% |
| 2013 FY | 983.71 Million CNY | 24.7% |
| 2013 Q3 | 1.02 Billion CNY | 10.64% |
| 2013 Q2 | 930.59 Million CNY | -6.4% |
| 2013 Q1 | 994.18 Million CNY | 26.03% |
| 2012 FY | 788.87 Million CNY | 102.67% |
| 2012 Q2 | 85.75 Million CNY | 50.09% |
| 2012 Q1 | 57.13 Million CNY | -85.32% |
| 2012 Q3 | 173.13 Million CNY | 101.9% |
| 2012 Q4 | 788.87 Million CNY | 355.65% |
| 2011 Q2 | 223.57 Million CNY | 18.8% |
| 2011 FY | 389.23 Million CNY | 444.56% |
| 2011 Q4 | 389.23 Million CNY | 25.56% |
| 2011 Q3 | 310 Million CNY | 38.66% |
| 2011 Q1 | 188.18 Million CNY | 163.28% |
| 2010 Q2 | -42.62 Million CNY | -303.1% |
| 2010 Q3 | -1.54 Million CNY | 96.38% |
| 2010 Q4 | 71.47 Million CNY | 4734.83% |
| 2010 Q1 | 20.98 Million CNY | 366.67% |
| 2010 FY | 71.47 Million CNY | 1008.19% |
| 2009 Q2 | 29.01 Million CNY | -42.39% |
| 2009 FY | -7.87 Million CNY | -116.98% |
| 2009 Q3 | 103.71 Million CNY | 257.42% |
| 2009 Q1 | 50.37 Million CNY | 8.68% |
| 2009 Q4 | -7.87 Million CNY | -107.59% |
| 2008 Q2 | 39.29 Million CNY | -23.81% |
| 2008 FY | 46.35 Million CNY | 952.2% |
| 2008 Q1 | 51.57 Million CNY | 1048.21% |
| 2008 Q4 | 46.35 Million CNY | -23.81% |
| 2008 Q3 | 60.83 Million CNY | 54.82% |
| 2007 FY | -5.43 Million CNY | -107.48% |
| 2007 Q3 | -88.37 Million CNY | 16.38% |
| 2007 Q1 | 33.91 Million CNY | -53.34% |
| 2007 Q2 | -105.68 Million CNY | -411.57% |
| 2007 Q4 | -5.43 Million CNY | 93.85% |
| 2006 Q2 | 122.27 Million CNY | 35.85% |
| 2006 Q1 | 90 Million CNY | 61.37% |
| 2006 Q4 | 72.69 Million CNY | -44.53% |
| 2006 FY | 72.69 Million CNY | 30.33% |
| 2006 Q3 | 131.05 Million CNY | 7.18% |
| 2005 Q2 | 220.27 Million CNY | -12.42% |
| 2005 Q4 | 55.77 Million CNY | -69.94% |
| 2005 Q3 | 185.53 Million CNY | -15.77% |
| 2005 Q1 | 251.5 Million CNY | 15.18% |
| 2005 FY | 55.77 Million CNY | -74.45% |
| 2004 Q4 | 218.35 Million CNY | -1.69% |
| 2004 Q1 | 12.67 Million CNY | 131.83% |
| 2004 Q3 | 222.09 Million CNY | 110.49% |
| 2004 FY | 218.35 Million CNY | 648.21% |
| 2004 Q2 | 105.51 Million CNY | 732.3% |
| 2003 FY | -39.83 Million CNY | 75.63% |
| 2003 Q1 | -122.68 Million CNY | 24.95% |
| 2003 Q2 | -99.97 Million CNY | 18.51% |
| 2003 Q3 | -45.55 Million CNY | 54.43% |
| 2003 Q4 | -39.83 Million CNY | 12.57% |
| 2002 Q3 | -204.45 Million CNY | 17.69% |
| 2002 Q1 | -290.75 Million CNY | -2.04% |
| 2002 FY | -163.46 Million CNY | 42.63% |
| 2002 Q2 | -248.41 Million CNY | 14.56% |
| 2002 Q4 | -163.46 Million CNY | 20.05% |
| 2001 Q4 | -284.93 Million CNY | 0.0% |
| 2001 Q2 | -9.64 Million CNY | 0.0% |
| 2001 FY | -284.93 Million CNY | -1315.75% |
| 2000 FY | -20.12 Million CNY | -140.47% |
| 2000 Q4 | -20.12 Million CNY | 0.0% |
| 2000 Q2 | 24.89 Million CNY | 0.0% |
| 1999 FY | 49.72 Million CNY | -83.91% |
| 1999 Q4 | 49.72 Million CNY | 0.0% |
| 1999 Q2 | 20.44 Million CNY | 0.0% |
| 1998 Q4 | 309.07 Million CNY | 0.0% |
| 1998 FY | 309.07 Million CNY | 878.0% |
| 1998 Q2 | 38.06 Million CNY | 0.0% |
| 1997 Q4 | 31.6 Million CNY | 0.0% |
| 1997 FY | 31.6 Million CNY | -54.33% |
| 1997 Q2 | - CNY | 0.0% |
| 1996 FY | 69.19 Million CNY | -73.66% |
| 1996 Q4 | 69.19 Million CNY | 0.0% |
| 1995 FY | 262.71 Million CNY | 32.76% |
| 1994 FY | 197.89 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Pak Fah Yeow International Limited | -258.7 Million HKD | 270.218% |
| Grand Pharmaceutical Group Limited | 2.03 Billion HKD | 78.327% |
| Extrawell Pharmaceutical Holdings Limited | 5.94 Million HKD | -7308.449% |
| Wai Yuen Tong Medicine Holdings Limited | 301.53 Million HKD | -46.038% |
| Qianhai Health Holdings Limited | -19.03 Million HKD | 2413.049% |
| Lee's Pharmaceutical Holdings Limited | 30.94 Million HKD | -1322.897% |
| Essex Bio-Technology Limited | -219.22 Million HKD | 300.867% |
| Tongfang Kontafarma Holdings Limited | 256.16 Million HKD | -71.905% |
| PuraPharm Corporation Limited | 377.54 Million HKD | -16.636% |
| SSY Group Limited | 1.71 Billion HKD | 74.301% |
| JBM (Healthcare) Limited | -7.39 Million HKD | 6051.591% |
| Jacobson Pharma Corporation Limited | 337.44 Million HKD | -30.499% |
| China Resources Pharmaceutical Group Limited | 50.97 Billion HKD | 99.136% |